CS-PEI/Beclin-siRNA Downregulate Multidrug Resistance Proteins and Increase Paclitaxel Therapeutic Efficacy against NSCLC
- PMID: 31336235
- PMCID: PMC6656922
- DOI: 10.1016/j.omtn.2019.06.017
CS-PEI/Beclin-siRNA Downregulate Multidrug Resistance Proteins and Increase Paclitaxel Therapeutic Efficacy against NSCLC
Abstract
Paclitaxel (PTX) is a widely used chemotherapy drug; however, frequent use causes multidrug resistance (MDR), which limits the utility of PTX against advanced non-small-cell lung cancer (NSCLC). PTX-resistant subline (NCI-H23-TXR) was established in vitro by exposing NCI-H23 cells to gradually increased concentrations of PTX in culture medium. Distinct Beclin expression of autophagy level was observed between resistant NCI-H23-TXR and parental NCI-H23 cells. Beclin-small interfering RNA (siRNA) was selected to restore sensitivity of PTX against NCI-H23-TXR. Chondroitin sulfate-polyethylenimine (CS-PEI) was constructed for delivery and protection of Beclin-siRNA. To delineate the underlying molecular mechanism of Beclin knockdown, we analyzed different MDR expression proteins of two cells using western blot, and the corresponding genes were confirmed by real-time PCR. Compared with NCI-H23, NCI-H23-TXR had higher expression levels in P-glycoprotein (P-gp) and multidrug resistance protein 7 (ABCC10). Knockdown of Beclin simultaneously inhibited P-gp and ABCC10, and renewed the sensitivity of PTX against NCI-H23-TXR. Research on zebrafish embryos revealed that tumor sizes decreased in NCI-H23 tumor xenografts but remained intact in NCI-H23-TXR tumor xenografts as zebrafish were treated with 1 μg/mL PTX. In contrast, the tumor sizes decreased in NCI-H23-TXR tumor xenografts with zebrafish pre-transfected with CS-PEI/Beclin-siRNA followed by the same treatment of PTX. The role of autophagy was associated with MDR development. This study paves the way for a new avenue of PTX in MDR-related lung cancer therapy using CS-PEI as a gene delivery carrier.
Keywords: Beclin-siRNA; MDR; PTX; autophagy; multidrug resistance; non-viral gene delivery vector; paclitaxel.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Figures








Similar articles
-
The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines.Biomed Pharmacother. 2011 Aug;65(5):345-53. doi: 10.1016/j.biopha.2011.04.015. Epub 2011 Jun 12. Biomed Pharmacother. 2011. PMID: 21775090
-
[Cytological Study in vitro on Co-delivery of siRNA and Paclitaxel within Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Tumors].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2016 Feb;33(1):108-14. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2016. PMID: 27382749 Chinese.
-
The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.Prostate. 2007 Jun 15;67(9):955-67. doi: 10.1002/pros.20581. Prostate. 2007. PMID: 17440963
-
ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer.Oncol Rep. 2009 Jan;21(1):263-8. Oncol Rep. 2009. PMID: 19082471
-
MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer.Mol Cancer Ther. 2008 May;7(5):1150-5. doi: 10.1158/1535-7163.MCT-07-2088. Epub 2008 Apr 29. Mol Cancer Ther. 2008. PMID: 18445659
Cited by
-
Synergistic Combination of Sodium Aescinate-Stabilized, Polymer-Free, Twin-Like Nanoparticles to Reverse Paclitaxel Resistance.Int J Nanomedicine. 2020 Aug 6;15:5839-5853. doi: 10.2147/IJN.S259432. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32848393 Free PMC article.
-
Zebrafish in Lung Cancer Research.Cancers (Basel). 2023 Sep 26;15(19):4721. doi: 10.3390/cancers15194721. Cancers (Basel). 2023. PMID: 37835415 Free PMC article. Review.
-
Autophagy Modulators: Mechanistic Aspects and Drug Delivery Systems.Biomolecules. 2019 Sep 25;9(10):530. doi: 10.3390/biom9100530. Biomolecules. 2019. PMID: 31557936 Free PMC article. Review.
-
Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer.Cancers (Basel). 2019 Nov 11;11(11):1775. doi: 10.3390/cancers11111775. Cancers (Basel). 2019. PMID: 31717997 Free PMC article. Review.
-
Zebrafish tumour xenograft models: a prognostic approach to epithelial ovarian cancer.NPJ Precis Oncol. 2024 Feb 27;8(1):53. doi: 10.1038/s41698-024-00550-9. NPJ Precis Oncol. 2024. PMID: 38413842 Free PMC article.
References
-
- Yeh J.J., Hsu W.H., Wang J.J., Ho S.T., Kao A. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer with P-glycoprotein expression. Respiration. 2003;70:32–35. - PubMed
-
- Kim Y.D., Park T.E., Singh B., Maharjan S., Choi Y.J., Choung P.H., Arote R.B., Cho C.S. Nanoparticle-mediated delivery of siRNA for effective lung cancer therapy. Nanomedicine (Lond.) 2015;10:1165–1188. - PubMed
-
- Georgiadis M.S., Russell E.K., Gazdar A.F., Johnson B.E. Paclitaxel cytotoxicity against human lung cancer cell lines increases with prolonged exposure durations. Clin. Cancer Res. 1997;3:449–454. - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous